Discover 156 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
Featured
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Eugene OR, Los Angeles CA, Scottsdale AZ, Denver CO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase 2, Phase 3, Recruiting
Featured
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Eugene OR, Portland OR, Duarte CA, Irvine CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07365241
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Eugene OR, Seattle WA, Billings MT, La Jolla CA,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase 2, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Get alerts for new trials in your area by subscribing now
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Eugene OR, San Francisco CA, Salt Lake City UT,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase 1, Phase 2, Recruiting
Featured
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Sponsor: Brain Electrophysiology Laboratory Company
Sex: All
Age: 40 - 70+
Code: NCT05771844
Recruiting
Active & Responsive
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
for
Substance Abuse, Decision Making, Shared,
Location: Eugene OR
Sponsor: Chestnut Health Systems
Sex: All
Age: 18+
Code: NCT06852170
Recruiting
Active & Responsive
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass⢠Total Ankle System
for
Post Traumatic Arthritis, Osteoarthritis,
Location: Eugene OR, Morton Grove IL, South Bend IN,
Sponsor: Stryker Trauma and Extremities
Sex: All
Age: 21+
Code: NCT07118501
Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Eugene OR, Springfield OR, Corvallis OR, Albany OR,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Eugene OR, Portland OR, Vancouver WA, Seattle WA,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase 3, Recruiting
Active & Responsive
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
for
Polycythemia Vera
Location: Eugene OR, Seattle WA, Salt Lake City UT, Redlands CA,
Sponsor: Italfarmaco
Sex: All
Age: 18+
Code: NCT06093672
Phase 3, Recruiting
Active & Responsive
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
for
Solid Tumors
Location: Eugene OR, Bellingham WA, Vancouver, Bellflower CA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07415031
Phase 2, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Eugene OR, Portland OR, San Francisco CA, La Jolla CA,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase 2, Recruiting
Active & Responsive
C-Protein in Fatigue and Aging
for
Aging, Muscle Atrophy or Weakness, Sarcopenia in Elderly,
Location: Eugene OR
Sponsor: University of Oregon
Sex: All
Age: 18 - 70+
Code: NCT05926219
Recruiting
Active & Responsive
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
for
Keratoconus, Unstable, Bacterial Keratitis, Ectasia of Cornea
Location: Eugene OR
Sponsor: Pacific Clear Vision Institute
Sex: All
Age: 12 - 45
Code: NCT03918408
Phase 1, Recruiting
Active & Responsive
Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
for
Overweight or Obesity
Location: Springfield OR
Sponsor: ORI Community and Evaluation Services
Sex: All
Age: 18 - 70
Code: NCT07708064
Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
for
HR+ HER2- Breast Cancer
Location: Springfield OR, Los Angeles CA, Lone Tree CO, Austin TX,
Sponsor: Faeth Therapeutics
Sex: All
Age: 18+
Code: NCT07558733
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease